SMEs in the healthcare sector are invited to apply for a share of up to £12 million to develop innovative ideas that will help to detect, manage and treat disease.
The Biomedical Catalyst project, managed by Innovate UK, has up to £12 million to support innovative healthcare technologies and processes that could help to prevent disease or better manage and treat chronic health conditions.
Innovate UK is looking for projects across a range of fields including:
- stratified healthcare (both therapy and diagnostic components)
- advanced therapies (cell and gene therapy)
- digital health
- enabling medical technologies and devices
Funding is available for late-stage awards and could be for projects including:
- initial human proof-of-concept studies
- demonstration of clinical utility and effectiveness
- demonstration of safety and efficacy (including phase I and II clinical trials)
- developing production mechanisms
- market testing
- intellectual property protection
- The competition opens on 30 March 2017, and the deadline for registration is midday on 31 May 2017.
- Projects must be led by an SME either working alone or with others.
- Projects should between £250,000 and £4 million in size and last between 12 and 36 months.
- Businesses could attract up to 70% of their project costs.
- A briefing event for potential applicants takes place on 4 April 2017